ACADIA Pharmaceuticals Stock Price Up 6.4 percent - Still a Buy - MarketBeat

ACAD Stock  USD 18.69  0.32  1.74%   
About 55% of ACADIA Pharmaceuticals' shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding ACADIA Pharmaceuticals suggests that some traders are interested. The current market sentiment, together with ACADIA Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use ACADIA Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
ACADIA Pharmaceuticals Stock Price Up 6.4 percent - Still a Buy MarketBeat

Read at news.google.com
Google News at Macroaxis
  

ACADIA Pharmaceuticals Fundamental Analysis

We analyze ACADIA Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ACADIA Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ACADIA Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Sales

Price To Sales Comparative Analysis

ACADIA Pharmaceuticals is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

ACADIA Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ACADIA Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of ACADIA Pharmaceuticals could also be used in its relative valuation, which is a method of valuing ACADIA Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

ACADIA Pharmaceuticals Related Equities

HEPAHepion Pharmaceuticals   5.56   
0%
88.0%
MDGLMadrigal Pharmaceuticals   3.67   
0%
58.0%
RVPHReviva Pharmaceuticals   2.79   
0%
44.0%
AKROAkero Therapeutics   2.52   
0%
40.0%
PTCTPTC Therapeutics   2.06   
0%
32.0%
ATHAAthira Pharma   1.92   
0%
30.0%
VKTXViking Therapeutics   0.78   
0%
12.0%
KRYSKrystal Biotech   0.15   
2.0%
0%
BPMCBlueprint Medicines   0.24   
3.0%
0%
SRPTSarepta Therapeutics   0.87   
13.0%
0%
CABACabaletta Bio   1.27   
20.0%
0%
FBIOFortress Biotech   2.79   
44.0%
0%
TERNTerns Pharmaceuticals   6.28   
100.0%
0%

Complementary Tools for ACADIA Stock analysis

When running ACADIA Pharmaceuticals' price analysis, check to measure ACADIA Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACADIA Pharmaceuticals is operating at the current time. Most of ACADIA Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ACADIA Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ACADIA Pharmaceuticals' price. Additionally, you may evaluate how the addition of ACADIA Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Money Managers
Screen money managers from public funds and ETFs managed around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios